11-108331498-G-C
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PP3_StrongPP5_Very_Strong
The NM_000051.4(ATM):c.7570G>C(p.Ala2524Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,613,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A2524S) has been classified as Likely benign.
Frequency
Consequence
NM_000051.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | NM_000051.4 | MANE Select | c.7570G>C | p.Ala2524Pro | missense | Exon 51 of 63 | NP_000042.3 | ||
| ATM | NM_001351834.2 | c.7570G>C | p.Ala2524Pro | missense | Exon 52 of 64 | NP_001338763.1 | |||
| C11orf65 | NR_147053.3 | n.2442C>G | non_coding_transcript_exon | Exon 13 of 13 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATM | ENST00000675843.1 | MANE Select | c.7570G>C | p.Ala2524Pro | missense | Exon 51 of 63 | ENSP00000501606.1 | ||
| ATM | ENST00000452508.7 | TSL:1 | c.7570G>C | p.Ala2524Pro | missense | Exon 52 of 64 | ENSP00000388058.2 | ||
| ATM | ENST00000527805.6 | TSL:1 | n.*2634G>C | non_coding_transcript_exon | Exon 49 of 61 | ENSP00000435747.2 |
Frequencies
GnomAD3 genomes AF: 0.00000659 AC: 1AN: 151792Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000239 AC: 6AN: 251298 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461366Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 726986 show subpopulations
GnomAD4 genome AF: 0.00000659 AC: 1AN: 151792Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74124 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Ataxia-telangiectasia syndrome Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 2524 of the ATM protein (p.Ala2524Pro). This variant is present in population databases (rs769142993, gnomAD 0.03%). This missense change has been observed in individual(s) with ataxia-telangiectasia and/or ATM-related cancers (PMID: 10980530, 11897822, 16622469). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 187613). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects ATM function (PMID: 17166884, 22071889). For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Observed in the compound heterozygous or homozygous state in multiple unrelated patients with ataxia-telangiectasia, and confirmed to be on the opposite allele (in trans) with a pathogenic variant in at least one individual (PMID: 10980530, 11897822, 22071889); Published functional studies suggest a damaging effect: defective kinase activity (PMID: 17166884, 22071889); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16622469, 16914028, 30927251, 32853339, 35095854, 33436325, 32183364, 29922827, 36467798, 20346647, 11897822, 10980530, 19224889, 22071889, 17166884, 23532176, 36551643, 36161273, 37578974)
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.A2524P variant (also known as c.7570G>C), located in coding exon 50 of the ATM gene, results from a G to C substitution at nucleotide position 7570. The alanine at codon 2524 is replaced by proline, an amino acid with highly similar properties. This variant has been identified in the homozygous state and/or in conjunction with other ATM variant(s) in individual(s) with features consistent with ataxia telangiectasia (AT) (Allinen M et al. J Med Genet. 2002 Mar;39(3):192-6). This alteration has also been observed as heterozygous in multiple individuals diagnosed with breast or prostate cancer (Allinen M et al. J Med Genet. 2002 Mar;39(3):192-6; Bubien V et al. Genes Chromosomes Cancer. 2017 Nov;56(11):788-799; Nurmi A et al. Int. J. Cancer, 2019 11;145:2692-2700; Rantapero T et al. Genes (Basel), 2020 03;11:; Karlsson Q et al. Eur Urol Oncol, 2021 Aug;4:570-579). One functional study demonstrated that this alteration leads to a stable protein that is defective in kinase activity (Pylkas K et al. Carcinogenesis. 2007 May;28(5):1040-5). A second functional study demonstrated that this alteration leads to a significantly decreased response to ionizing radiation that is similar to that of a control AT cell line (Jacquemin V et al. Eur J Hum Genet. 2012 Mar;20(3):305-12). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at